Receipts
I write about Rocket Doctor AI (CSE: AIDR | OTC: AIRDF | FSE: 939) often enough that a fair question follows: is he actually long, or just talking?
I write about Rocket Doctor AI (CSE: AIDR | OTC: AIRDF | FSE: 939) often enough that a fair question follows: is he actually long, or just talking?
Here is the main position:

Here's yesterday's blotter:

Four fills on September 2: 40,000 shares of AIDR between $0.5700 and $0.5800. About $23,350 all-in including commission, or roughly $0.584 per share landed.
Where the dry powder comes from
I’ve left the sells in the same screenshot on purpose, because “where does this guy keep finding money to buy more” is a reasonable question and I’d rather answer it before someone has to ask.
That day, I sold 2,000 Berkshire CDRs at $36.57 and 1,500 Cardinal Energy at $12.13, about $91,000 in combined proceeds. That funded the AIDR buy, a 25,000-share position in Silver X Mining at $0.90, and left the balance in cash. No leverage, no margin, no outside money. I rotated out of two positions I’d held for a while and into two I’d rather own right now.
Worth noting before anyone else does: the Silver X buy was slightly larger in dollar terms than the AIDR buy that day. I’m not going to hide that to make the conviction story cleaner. AIDR remains the higher-weight position in my portfolio by a wide margin; a single day’s allocation isn’t the whole picture.
Why now
Nothing has changed in the past week that isn’t already public. The thesis is the same one I’ve been writing: Rocket Doctor has built payer access, roughly 21 million U.S. covered lives across about 20 insurers per the filed MD&A, well ahead of the revenue it currently recognizes against that footprint. The binding constraint is physician credentialing throughput, not patient demand.
I just covered Rocket Doctor (OTC: AIRDF): Q2 Is the Quarter the Skyscraper Came Above Ground here:
Rocket Doctor (OTC: AIRDF): Q2 Is the Quarter the Skyscraper Came Above Ground
YAZAN HOMSI·SEP 2

Source: Dr. Bill Cherniak, Co-Founder & CEO of Rocket Doctor Inc., video interview,
If that’s right, the market is still pricing the “before” picture while the structural work is largely done. If it’s wrong, credentialing conversion stays slow, U.S. revenue stays a small share of the total, and I’m early on something that doesn’t arrive. That’s the actual risk, and I’ve written about it before.
I’d rather add at $0.58 than write about it and do nothing.
One caveat on posting fills
I’ve historically disclosed my position as a share count and a portfolio weight rather than posting trade-by-trade screenshots, for a reason: showing buys and not showing sells is how people get misled. So the standard I’m setting here is symmetrical: if I ever materially reduce this position, I’ll say so with the same specificity.
This isn’t a trade alert service, and I’m not going to post every fill. I’m posting these because a lot of people have asked whether I’m actually in this, and screenshots answer that faster than another thousand words of thesis.
Disclosure: I am a long AIDR holder of over 1.5M shares, including the 40,000 shares shown above. I have no relationship with the company and am not compensated for writing about it. I also hold a position in Silver X Mining as shown. Prices are in CAD. Nothing here is investment advice. NFA. DYOR.
This article reflects personal research and opinions and is provided for informational purposes only. It is not financial advice, a recommendation to buy or sell any security, or a consideration of your individual circumstances. Investing in small-cap and pre-commercialization companies involves significant risk, including the risk of total loss. Always do your own research and consider speaking with a qualified financial professional before making investment decisions.
Stay Informed with The Wire
Get the latest insights and analysis on public companies delivered directly to your inbox.



